# Dysregulation of the DNA damage response by phosphorothioate antisense oligonucleotides

**Authors:** Linn Hjelmgren, Qianyu Zhou, Sandro Schmidli, Manon Gloudemans, Tomasz Czapik, Samantha Roudi, Malgorzata Honcharenko, Daniel W. Hagey, Samir EL Andaloussi, Marianne Farnebo

PMC · DOI: 10.1038/s41467-026-69980-2 · Nature Communications · 2026-02-27

## TL;DR

This paper shows how certain antisense oligonucleotides disrupt DNA repair processes, leading to toxic DNA damage.

## Contribution

The study reveals that phosphorothioate ASOs trigger DNA repair enzyme activation and condensate formation without DNA damage.

## Key findings

- Phosphorothioate ASOs bind DNA repair enzymes and form nuclear condensates.
- ASO-induced condensates activate DNA damage response and disrupt repair processes.
- This dysregulation leads to toxic DNA lesions and cell cycle checkpoint activation.

## Abstract

Phosphorothioate (PS)-modified antisense oligonucleotides (ASOs) are widely used to modulate gene expression in basic research and therapy. Within cells, these ASOs seed nuclear structures with unclear functions and consequences. At DNA breaks, endogenous nucleotide polymers drive the assembly of biomolecular condensates that recruit repair proteins, but the underlying mechanism(s) and effects on repair enzyme activation are poorly understood. Here, we show that ASOs bind to DNA-PKcs, ATM, and PARP1, triggering phase separation and formation of nuclear condensates containing ASOs and these essential repair enzymes. Condensates assembly is stimulated by ASO concentration and ATM activity, while limited by DNA-PKcs activity. Notably, these condensates become enzymatically active and erroneously elicit the DNA damage response in the absence of DNA damage, activating cell cycle checkpoints, disturbing endogenous repair and causing accumulation of toxic DNA lesions. These findings uncover mechanisms for ASO toxicity and the activation of DNA repair enzymes by nucleotide polymers.

Antisense oligonucleotides (ASOs) are used in research and therapy. Here, the authors show that PS-modified ASOs bind key DNA repair enzymes and form nuclear condensates that dysregulate the DNA damage response, disrupt DNA repair, and cause toxic DNA lesions, revealing mechanisms underlying ASO-induced toxicity.

## Linked entities

- **Proteins:** PRKDC (protein kinase, DNA-activated, catalytic subunit), ATM (ATM serine/threonine kinase), PARP1 (poly(ADP-ribose) polymerase 1)
- **Chemicals:** phosphorothioate (PubChem CID 167253)

## Full-text entities

- **Genes:** RAD50 (RAD50 double strand break repair protein) [NCBI Gene 10111] {aka NBSLD, RAD502, hRad50}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672] {aka BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4}, ATRIP (ATR interacting protein) [NCBI Gene 84126], XRCC6 (X-ray repair cross complementing 6) [NCBI Gene 2547] {aka CTC75, CTCBF, G22P1, KU70, ML8, TLAA}, TAF15 (TATA-box binding protein associated factor 15) [NCBI Gene 8148] {aka Npl3, RBP56, TAF2N, TAFII68}, H2ax (H2A.X variant histone) [NCBI Gene 15270] {aka H2A.X, H2afx, Hist5-2ax, gammaH2ax}, BRCA2 (BRCA2 DNA repair associated) [NCBI Gene 675] {aka BRCC2, BROVCA2, FACD, FAD, FAD1, FANCD}, ATR [NCBI Gene 106591441], Prkdc (protein kinase, DNA activated, catalytic polypeptide) [NCBI Gene 19090] {aka DNA-PKcs, DNAPDcs, DNAPK, DNPK1, DOXNPH, HYRC1}, TARDBP (TAR DNA binding protein) [NCBI Gene 23435] {aka ALS10, TDP-43}, ATM [NCBI Gene 106612994], EWSR1 (EWS RNA binding protein 1) [NCBI Gene 2130] {aka EWS, EWS-FLI1}, MARVELD2 (MARVEL domain containing 2) [NCBI Gene 153562] {aka DFNB49, MARVD2, MRVLDC2, Tric}, CCT2 (chaperonin containing TCP1 subunit 2) [NCBI Gene 10576] {aka 99D8.1, CCT-beta, CCTB, HEL-S-100n, PRO1633, TCP-1-beta}, PRKDC (protein kinase, DNA-activated, catalytic subunit) [NCBI Gene 5591] {aka DNA-PKC, DNA-PKcs, DNAPK, DNAPKc, DNPK1, HYRC}, H2AX (H2A.X variant histone) [NCBI Gene 3014] {aka H2A.X, H2A/X, H2AFX}, Tcp1 (t-complex protein 1) [NCBI Gene 21454] {aka CCT, Cct1, Ccta, TRic, Tcp-1, Tp63}, TP53BP1 (tumor protein p53 binding protein 1) [NCBI Gene 7158] {aka 53BP1, TDRD30, p202, p53BP1}, SCARNA2 (small Cajal body-specific RNA 2) [NCBI Gene 677766] {aka HBII-382, mgU2-25/61}, LIG4 (DNA ligase 4) [NCBI Gene 3981] {aka LIG4S}, XRCC1 (X-ray repair cross complementing 1) [NCBI Gene 7515] {aka RCC, SCAR26}, NBN (nibrin) [NCBI Gene 4683] {aka AT-V1, AT-V2, ATV, NBS, NBS1, P95}, FUS (FUS RNA binding protein) [NCBI Gene 2521] {aka ALS6, ETM4, FUS1, HNRNPP2, POMP75, TLS}, RPA2 (replication protein A2) [NCBI Gene 6118] {aka REPA2, RP-A p32, RP-A p34, RPA32}, ATR (ATR checkpoint kinase) [NCBI Gene 545] {aka FCTCS, FRP1, MEC1, SCKL, SCKL1}, CCT [NCBI Gene 907], CHEK2 (checkpoint kinase 2) [NCBI Gene 11200] {aka CDS1, CHK2, HuCds1, LFS2, PP1425, RAD53}, XRCC4 (X-ray repair cross complementing 4) [NCBI Gene 7518] {aka SSMED, hXRCC4}, MDC1 (mediator of DNA damage checkpoint 1) [NCBI Gene 9656] {aka NFBD1}, NUCLEOLIN (nucleolin multifunctional protein) [NCBI Gene 4691] {aka C23, NCL, Nsr1}, CCNA2 (cyclin A2) [NCBI Gene 890] {aka CCN1, CCNA}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, TFPI (tissue factor pathway inhibitor) [NCBI Gene 7035] {aka EPI, LACI, TFI, TFPI1}, TOPBP1 (DNA topoisomerase II binding protein 1) [NCBI Gene 11073] {aka Dpb11, TOP2BP1}, RAD51 (RAD51 recombinase) [NCBI Gene 5888] {aka BRCC5, FANCR, HRAD51, HsRad51, HsT16930, MRMV2}, RPA1 (replication protein A1) [NCBI Gene 6117] {aka HSSB, MST075, PFBMFT6, REPA1, RF-A, RP-A}, XRCC5 (X-ray repair cross complementing 5) [NCBI Gene 7520] {aka KARP-1, KARP1, KU80, KUB2, Ku86, NFIV}, RAD52 (RAD52 DNA repair protein) [NCBI Gene 5893], DNTT (DNA nucleotidylexotransferase) [NCBI Gene 1791] {aka TDT}, Parp1 (poly (ADP-ribose) polymerase family, member 1) [NCBI Gene 11545] {aka 5830444G22Rik, ARTD1, Adprp, Adprt1, PARP, PPOL}, RNASE1 (ribonuclease A family member 1, pancreatic) [NCBI Gene 6035] {aka RAC1, RIB1, RNS1}, ATM (ATM serine/threonine kinase) [NCBI Gene 472] {aka AT1, ATA, ATC, ATD, ATDC, ATE}, TCP1 (t-complex 1) [NCBI Gene 6950] {aka CCT-alpha, CCT1, CCTa, D6S230E, IDDPMGS, TCP-1-alpha}, PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142] {aka ADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, NR1I2 (nuclear receptor subfamily 1 group I member 2) [NCBI Gene 8856] {aka BXR, ONR1, PAR, PAR1, PAR2, PARq}
- **Diseases:** toxicity (MESH:D064420), pain (MESH:D010146)
- **Chemicals:** argon (MESH:D001128), 4',6-diamidino-2-phenylindole (MESH:C007293), DMSO (MESH:D004121), buprenorphine (MESH:D002047), KCl (MESH:D011189), Tween 20 (MESH:D011136), NAD+ (MESH:D009243), Olaparib (MESH:C531550), agarose (MESH:D012685), VE-821 (MESH:C560580), ATRi (MESH:C069225), ammonium acetate (MESH:C018824), sucrose (MESH:D013395), PFA (MESH:C003043), CO2 (MESH:D002245), thiophosphates (MESH:C035638), 4-hydroxytamoxifen (MESH:C016601), L-Glutamine (MESH:D005973), ATP (MESH:D000255), oil (MESH:D009821), ASO (MESH:D016376), 1,6-hexanediol (MESH:C027765), Lipofectamine 2000 (MESH:C086724), dUTP (MESH:C027078), CuSO4 (MESH:D019327), glycerol (MESH:D005990), poly-ADP-ribose (MESH:D011064), sulfur (MESH:D013455), 5'Cy3 (-), aluminum (MESH:D000535), NaOH (MESH:D012972), ethanol (MESH:D000431), SDS (MESH:D012967), ascorbic acid (MESH:D001205), 5-ethynyl 2 -deoxyuridine (MESH:C031086), oligonucleotides (MESH:D009841), locked nucleic acids (MESH:C477371), TRIzol (MESH:C411644), TBS (MESH:D013725), KU-60019 (MESH:C546193), isoflurane (MESH:D007530), nucleotide (MESH:D009711), NaN3 (MESH:D019810), 4-Thiouridine (MESH:D013891), NU7441 (MESH:C499693), H2O (MESH:D014867), polymers (MESH:D011108), acetonitrile (MESH:C032159), ADP (MESH:D000244), Triton X-100 (MESH:D017830), EDTA (MESH:D004492), Xylene (MESH:D014992), 5-Bromo-2'-deoxyuridine (MESH:D001973), NP40 (MESH:C010615), KU55933 (MESH:C495818), ammonia (MESH:D000641), oxygen (MESH:D010100), sugar (MESH:D000073893), AZD-7648 (MESH:C000705750), salt (MESH:D012492)
- **Species:** Homo sapiens (human, species) [taxon 9606], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), RPE-1 — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_4388), CHO — Cricetulus griseus (Chinese hamster), Spontaneously immortalized cell line (CVCL_0213), U2OS — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0042), MelJuSo — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_1403)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12954066/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12954066/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12954066/full.md

---
Source: https://tomesphere.com/paper/PMC12954066